Putting It in Writing

Somya Gupta, Farhat Ahmed, Ramya Krishnadas
{"title":"Putting It in Writing","authors":"Somya Gupta, Farhat Ahmed, Ramya Krishnadas","doi":"10.21423/jrs.regsci.111266","DOIUrl":null,"url":null,"abstract":"In the medical device industry, the practice of creating a \"Letter to File,\" \"Note to File,\" or \"Memo to File\" is employed to document modifications to a device in the USA for regulatory and compliance purposes. Although the U.S. Food and Drug Administration (FDA) have provided guidance on this topic over the years, there has not been a thorough exploration of this concept. Medical device manufacturers frequently make changes to their FDA-cleared products, but determining whether to handle the change internally using a Letter to File or notify the FDA can be unclear. This article provides a comprehensive overview of what a Letter to File is, the purpose of writing one, and the appropriate situations in which a company might use it. Additionally, it also discusses the contents of a typical Letter to File, including the necessary elements and the best practices for writing it effectively and consequences of making the wrong decision. By providing guidance on the Letter to File process, this article aims to assist professionals in the medical device industry in maintaining precise records that can support their organizations in any regulatory situation.","PeriodicalId":263660,"journal":{"name":"Journal of Regulatory Science","volume":"17 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Regulatory Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21423/jrs.regsci.111266","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In the medical device industry, the practice of creating a "Letter to File," "Note to File," or "Memo to File" is employed to document modifications to a device in the USA for regulatory and compliance purposes. Although the U.S. Food and Drug Administration (FDA) have provided guidance on this topic over the years, there has not been a thorough exploration of this concept. Medical device manufacturers frequently make changes to their FDA-cleared products, but determining whether to handle the change internally using a Letter to File or notify the FDA can be unclear. This article provides a comprehensive overview of what a Letter to File is, the purpose of writing one, and the appropriate situations in which a company might use it. Additionally, it also discusses the contents of a typical Letter to File, including the necessary elements and the best practices for writing it effectively and consequences of making the wrong decision. By providing guidance on the Letter to File process, this article aims to assist professionals in the medical device industry in maintaining precise records that can support their organizations in any regulatory situation.
把它写下来
在医疗器械行业,为了监管和合规的目的,在美国,创建“致文件的信”、“致文件的注释”或“致文件的备忘录”的做法被用来记录设备的修改。尽管美国食品和药物管理局(FDA)多年来一直就这一主题提供指导,但尚未对这一概念进行彻底的探索。医疗器械制造商经常对其FDA批准的产品进行更改,但决定是否使用提交信或通知FDA来内部处理更改可能并不清楚。本文全面概述了什么是Letter to File,写Letter to File的目的,以及公司可能使用Letter to File的适当情况。此外,本文还讨论了典型的致文件信的内容,包括有效撰写致文件信的必要元素和最佳实践,以及做出错误决策的后果。通过提供有关“提交申请信”流程的指导,本文旨在帮助医疗器械行业的专业人员维护精确的记录,从而在任何监管情况下为其组织提供支持。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信